GSK Investigational Site

Golnik 4204

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Pulmonary Disease, Chronic Obstructive

Studies at this site

• A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype — Completed
• Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints — Completed